Workflow
莱美药业(300006) - 2019 Q3 - 季度财报
LummyLummy(SZ:300006)2019-10-27 16:00

Financial Performance - Operating revenue for the period reached CNY 503,658,685.93, a year-on-year increase of 35.49%[7] - Net profit attributable to shareholders was CNY 22,179,475.68, reflecting a growth of 15.11% year-on-year[7] - Net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 11.09% to CNY 15,434,485.46[7] - Basic earnings per share for the period was CNY 0.0273, up 15.19% year-on-year[7] - Total operating revenue for Q3 2019 was CNY 503.66 million, an increase of 35.4% compared to CNY 371.73 million in the same period last year[38] - Net profit for Q3 2019 was CNY 15.39 million, a decrease of 13.3% from CNY 17.70 million in Q3 2018[39] - Basic and diluted earnings per share increased to ¥0.0776 from ¥0.0557, reflecting a growth of approximately 39.5%[52] - The net profit for the period was CNY 75,442,737.81, down 21.9% from CNY 96,581,212.17 in the same period last year[47] Assets and Liabilities - Total assets increased by 14.71% to CNY 3,602,891,712.29 compared to the end of the previous year[7] - Total liabilities rose to CNY 1,788,619,405.03 from CNY 1,416,736,781.16, which is an increase of about 26%[30] - The company's total equity increased to CNY 1,814,272,307.26 from CNY 1,724,040,893.32, showing a growth of approximately 5%[31] - Total current assets increased to CNY 1,722,708,989.13 from CNY 1,287,281,098.31, representing a growth of approximately 34% year-over-year[29] - The total liabilities stood at 1,214,421,562.10 CNY, remaining stable compared to previous periods, indicating consistent debt management[64] Cash Flow - Cash flow from operating activities for the year-to-date was CNY 130,542,309.25, an increase of 74.18%[7] - Operating cash flow net amount increased by 74.18% to ¥130,542,309.25 driven by higher cash received from sales of goods and services[18] - Cash flow from operating activities generated a net amount of ¥130,542,309.25, up from ¥74,946,590.23, indicating a growth of approximately 74.5%[56] - Cash flow from investing activities resulted in a net outflow of ¥180,924,479.60, an improvement from a net outflow of ¥279,798,902.08 in the prior year[56] - The company's cash and cash equivalents decreased to CNY 187.53 million from CNY 234.59 million year-over-year[35] Shareholder Information - The total number of shareholders at the end of the reporting period was 35,837[11] - The largest shareholder, Qiu Yu, holds 22.71% of the shares, with 184,497,185 shares, of which 138,372,889 are frozen[11] - A cash dividend of ¥0.5 per share was distributed, totaling ¥40,612,060.25, approved by the 2018 annual general meeting[22] Expenses - Sales expenses increased by 56.42% to ¥638,567,365.83 due to optimized marketing strategies and increased market development efforts[16] - Financial expenses grew by 51.59% to ¥53,151,064.06 mainly due to increased financing activities[16] - Research and development expenses for Q3 2019 were CNY 7.34 million, a decrease of 36.5% from CNY 11.53 million in Q3 2018[38] - R&D expenses increased to ¥13,931,534.33 from ¥12,733,679.28, reflecting a growth of approximately 9.4% year-over-year[51] Investment Activities - The company reported a 89.26% decrease in investment income to ¥4,729,990.70 due to the sale of Athenex shares[16] - The company experienced a decrease in investment income, reporting CNY 4,729,990.70 compared to CNY 44,032,846.40 in the previous period[45] - The cash inflow from investment activities was 143,500,424.56 CNY, a significant rise from 16,390,648.93 CNY, indicating a more aggressive investment approach[59] Changes in Control - The company plans to transfer 22.71% of its shares to Nanchuan Urban Construction Development Group, which may lead to a change in control[19] Financial Reporting Changes - The company has implemented new financial instrument standards starting from 2019, which may affect future financial reporting[70]